H.B. Fuller Faces Opposition Over AMS Acquisition Amid Stock Decline
H.B. Fuller Company’s stock has dropped 6.40% as it crosses below the 5-day SMA, reflecting investor concerns following the announcement of its acquisition of Advanced Medical Solutions (AMS).
Ancora Holdings has strongly opposed H.B. Fuller’s acquisition of AMS, claiming that the management has prioritized self-preservation over shareholder value. They argue that the timing of the acquisition announcement was strategic to mitigate backlash, which has raised concerns about corporate governance and trust. Ancora intends to hold the board accountable, particularly criticizing the decision to pursue a highly leveraged acquisition that contradicts previous commitments to shareholders.
The implications of this opposition could lead to increased scrutiny of H.B. Fuller’s management decisions and potential challenges in executing the acquisition. Investors may remain cautious as the company navigates these governance issues while attempting to expand its market presence.
Trade with 70% Backtested Accuracy
Analyst Views on FUL
About FUL
About the author

- Earnings Beat: H.B. Fuller reported a 9% year-over-year increase in adjusted EBITDA to $181 million for Q2 2026, surpassing expectations and demonstrating strong execution amid global sourcing and rapid pricing strategies during supply disruptions.
- Revenue Growth: The company achieved revenues of $950.3 million, exceeding the Zacks Consensus Estimate of $926.9 million, resulting in a surprise rate of 2.5%, indicating effective strategic shifts towards medical adhesives.
- Record Cash Flow: Operating cash flow reached a record $121 million, with net debt to adjusted EBITDA improving to 3.1 times, reflecting robust financial management that supports future investments and acquisitions.
- Strategic Acquisition Plan: H.B. Fuller proposed an all-cash offer of 285 pence per share for Advanced Medical Solutions, which is expected to expand its medical adhesives platform more than fourfold and push combined medical business EBITDA margins above 30% by 2030.
- Market Decline: The S&P 500 and Nasdaq 100 fell by 0.05% and 1.09% respectively on Friday, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which could undermine investor confidence.
- Chipmaker Sell-off: The significant drop in Samsung Electronics and SK Hynix shares led to a more than 5% decline in South Korea's Kospi Index, triggering a global downturn in semiconductor stocks and exacerbating market uncertainty.
- Oil Price Impact: WTI crude oil prices fell over 3% to a four-month low on Friday, which helps lower inflation expectations and supports the stock market, but also reflects potential slowdowns in global economic growth.
- Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward by 0.6 to 49.5, although still below the expected 50.0, indicating a cautious consumer outlook that may affect future spending.
- Upgraded Outlook: J.P. Morgan upgraded H.B. Fuller from Neutral to Overweight with a price target increase from $58 to $67, reflecting the company's ability to grow adjusted EBITDA through price increases and positive currency effects in a flat to declining volume environment.
- EBITDA Growth Insights: Analyst Jeffrey Zekauskas noted that H.B. Fuller's adjusted EBITDA for Q2 2026 increased by 9% due to a 3% price hike and a 3% positive currency effect, while H1 saw a 4% growth, demonstrating effective cost control and pricing strategies.
- Volume Forecast Adjustment: Although H.B. Fuller anticipates a 4%-6% decline in volume for H2, Zekauskas believes this estimate may be overly pessimistic, as the company claims that quarter-to-date volumes are flat and comparable to Q2 year-over-year rates, indicating potentially stable market demand.
- Cost Control Strategy: The company is downsizing its manufacturing footprint to cut costs, and the analyst suggests that lower oil prices and the opening of the Strait of Hormuz are likely to alleviate raw material cost pressures in 2027, further enhancing the company's profitability.
- Market Weakness: The S&P 500 and Nasdaq 100 indices fell by 0.07% and 0.75%, respectively, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which may lead to declining investor confidence.
- Chip Stock Plunge: The significant sell-off of Samsung Electronics and SK Hynix caused the South Korean Kospi index to drop over 5%, triggering a global decline in chip stocks and exacerbating market uncertainty.
- Oil Price Decline Impact: WTI crude oil prices fell by more than 3%, easing inflation expectations and supporting stocks; however, the recovery of crude exports to 75% of pre-war levels may influence future market dynamics.
- Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward to 49.5, although still below the expected 50.0, reflecting cautious consumer attitudes towards the economic outlook, which could affect retail and consumer-related stocks.
- Market Decline: The S&P 500 index fell by 0.54% and the Nasdaq 100 dropped by 1.38%, both hitting two-week lows, indicating a weak market sentiment primarily driven by the poor performance of chipmakers, which significantly pressured the overall market.
- Chipmaker Sell-off: The sharp decline in Samsung Electronics and SK Hynix led to a more than 5% drop in South Korea's Kospi index, triggering a global sell-off in chip stocks and exacerbating investor concerns regarding the tech sector.
- Oil Price Impact: WTI crude oil prices fell by over 3% today, which not only eased inflation expectations but also lowered bond yields; however, the overall market remained under pressure due to weak stock performance.
- Software Stock Resilience: Despite the overall market downturn, software stocks like ServiceNow and Salesforce rose by over 6% and 4% respectively, somewhat limiting the market's downside, reflecting ongoing investor confidence in the software sector.
- Diageo Upgrade: TD Cowen upgraded Diageo from hold to buy, citing valuation dislocation as an attractive entry point, with CEO-led cost cuts and reinvestment expected to restore growth and enhance commercial execution.
- James Hardie Initiation: Stephens initiated coverage of James Hardie with an overweight rating and a $31 price target, highlighting its status as a high-quality company and its position as the second-largest composite decking manufacturer following its merger with AZEK.
- Nike Downgrade: KeyBanc downgraded Nike from overweight to sector weight, indicating that the turnaround is taking longer than anticipated, with slight reductions in FY27 estimates reflecting higher-than-expected headwinds in China and EMEA.
- American Tower Upgrade: RBC upgraded American Tower from sector perform to outperform, noting superior organic revenue growth compared to peers, despite rising interest rate pressures, indicating strong market potential.











